Total Funding
55
37
Total FundingSeries D raised
Growth Score
-12 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
187228
Atea Pharmaceuticals focuses on the discovery and development of next-generation therapeutics for severe human viral infections.
- Jean Sommadossi: Chief Executive Officer and FounderPast Role: Pharmasset, Co-Founder
Frank Yu: Director
About the Company
Atea Pharmaceuticals is a biopharmaceutical company engaged in the discovery and development of next-generation therapeutics for severe human viral infections. It caters to the healthcare industry and engages in the discovery and development of antiviral therapeutics that enable patients to have treatment for infections caused by RNA and DNA
viruses.
Atea Pharmaceuticals was established in 2014 and is headquartered in Boston, Massachusetts.
